Cyberounds Logo
March 12, 2010 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
ESRD in Diabetes: Choice of Therapy
CME credit is no longer available for this conference.
Eli A. Friedman, M.D.

Dr. Friedman has received grant/research support from Alteon within the past three years.

This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.


Release Date: 04/28/2002
Termination Date: 04/28/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
Educational Objectives
  • Discuss incidence and prevalence statistics pertaining to ESRD in diabetic patients
  • Describe current options in management for diabetic ESRD patients
  • Detail the survival advantage of hemodialysis over peritoneal dialysis for diabetic ESRD patients.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity